Maddalena Noviello
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.
Journal: Clinical lung cancer
Published: January 11, 2026
Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.
Journal: Med (New York, N.Y.)
Published: October 30, 2025
Impact of letermovir on cytomegalovirus-specific T-cell reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era.
Journal: Haematologica
Published: May 26, 2025
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.
Journal: Frontiers in immunology
Published: May 25, 2025
Beyond conventional adoptive T-cell therapy.
Journal: The Journal of allergy and clinical immunology
Published: February 21, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring.
Journal: Frontiers in immunology
Published: January 27, 2025
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
Journal: Frontiers in immunology
Published: February 02, 2024
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Journal: Science advances
Published: December 01, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
Journal: Bone marrow transplantation
Published: April 04, 2023
Histone-Specific CD4+ T Cell Plasticity in Active and Quiescent Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 23, 2023
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia.
Journal: Frontiers in immunology
Published: March 13, 2023
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies.
Journal: Frontiers in immunology
Published: December 23, 2022
Last Updated: 09/26/2026